1055 West Georgia Street
Vancouver, BC
Canada
https://www.mindbiotherapeutics.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees:
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Justin Adam Hanka | Co Founder, CEO & Director | N/A | N/A | 1974 |
Mr. John M. Dinan | Chief Financial Officer | N/A | N/A | 1958 |
Dr. Lahiru Russell Ph.D. | Chief Scientist | N/A | N/A | N/A |
MindBio Therapeutics Corp., together with its subsidiaries, operates as a clinical stage drug development company in Canada, Australia, and New Zealand. The company engages in researching, developing, and testing microdosing of psychedelic substances as a potential treatment for the management of various mental health conditions, such as depression, anxiety, PTSD, panic disorder, chronic pain, and opiate addictions. Its LSD-microdosing is currently under Phase 2 clinical trials for the treatment of major depressive disorder and microdosing of LSD in late-stage cancer patients. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.
MindBio Therapeutics Corp.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.